Prognosis Factors Associated With Convulsive Status Epilepticus in Adults

NCT ID: NCT00318578

Last Updated: 2007-08-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-03-31

Study Completion Date

2007-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to evaluate, prospectively, prognosis factors associated with convulsive status epilepticus (CSE) in adults hospitalized in intensive care units.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Status epilepticus is a neurologic and medical emergency associated with high mortality and morbidity rates. According to the operational definition Convulsive Status Epilepticus (CSE) is defined as a single clinical seizure lasting more than 10 min, or two or more repeated seizures over a period of more than 10 minutes without intervening recovery of consciousness.

There are a few to date in literature reporting prognosis factors associated with this condition and, at this time, there are no published data considering an operational definition of CSE.

In a retrospective study considering an operational definition we identified a seizure duration of 15 min associated with poor outcome (not yet published).

The principal goal of this study is to evaluate factors associated with outcome in CSE, in particular seizure duration of more than 15 minutes.

The secondary goals are to evaluate the epidemiology and management at every stage of CSE thus redefined.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Status Epilepticus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

DEFINED_POPULATION

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* More than 18 years old
* Convulsive status epilepticus according to operational definition as any seizure lasting for 10 minutes or longer, or two or more intermittent seizures lasting for greater than 10 minutes from which the patient did not regain consciousness.
* Beginning of seizure less than 12 hours before intensive care unit admission
* Convulsive status epilepticus occurring during intensive care unit stay

Exclusion Criteria

* Less than 18 years old
* Patients that seized up to 9 minutes
* Beginning of seizure more than 12 hours before intensive care unit admission
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Versailles Hospital

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephane LEGRIEL, MD

Role: PRINCIPAL_INVESTIGATOR

Versailles Hospital

Bruno MOURVILLIER, MD

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Bichat Claude Bernard

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier d'Abbeville

Abbeville, , France

Site Status

Centre Hospitalier d'Annonay

Annonay, , France

Site Status

Centre Hospitalier Victor Dupouy

Argenteuil, , France

Site Status

Centre Hospitalier Robert Ballanger

Aulnay-sous-Bois, , France

Site Status

Centre Hospitalier Rene Dubos

Cergy-Pontoise, , France

Site Status

Centre Hospitalier de Chartres

Chartres, , France

Site Status

Centre Hospitalier de Châlons-en-Champagne

Châlons-en-Champagne, , France

Site Status

Centre Hospitalier Universitaire Antoine Beclere

Clamart, , France

Site Status

Hopital Gabriel Montpied

Clermont-Ferrand, , France

Site Status

Centre Hospitalier de Compiegne

Compiègne, , France

Site Status

Centre Hospitalier Universitaire Henri Mondor

Créteil, , France

Site Status

Centre Hospitalier de Dourdan

Dourdan, , France

Site Status

Centre Hospitalier de Dreux

Dreux, , France

Site Status

Centre Hospitalier Universitaire de Grenoble

Grenoble, , France

Site Status

Centre Hospitalier de Versailles

Le Chesnay, , France

Site Status

Centre Hospitalier Universitaire La Timone

Marseille, , France

Site Status

Centre Hospitalier Sambre Avesnois

Maubeuge, , France

Site Status

Centre Hospitalier de Meaux

Meaux, , France

Site Status

Centre Hospitalier Universitaire de Nancy

Nancy, , France

Site Status

Centre Hospitalier Pierre Bérégovoy

Nevers, , France

Site Status

Centre Hôspitalier ARCHET

Nice, , France

Site Status

Centre Hospitalier Georges Renon

Niort, , France

Site Status

Centre Hospitalier Universitaire d'Orléans

Orléans, , France

Site Status

Centre Hospitalier Universitaire Cochin

Paris, , France

Site Status

Centre Hospitalier Universitaire Lariboisiere

Paris, , France

Site Status

Centre Hospitalier Bichat Claude Bernard

Paris, , France

Site Status

Fondation Hopital Saint Joseph

Paris, , France

Site Status

Centre Hospitalier Francois Mitterrand

Pau, , France

Site Status

Clinique Mutualiste de Pessas

Pessac, , France

Site Status

Centre Hospitalier Universitaire de Poitiers

Poitiers, , France

Site Status

Centre Hospitalier de Roanne

Roanne, , France

Site Status

Centre Hospitalier de Rodez

Rodez, , France

Site Status

Centre Hospitalier Mémorail France Etats Unis Saint Lo

Saint-Lô, , France

Site Status

Centre Hospitalier Foch

Suresnes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LEGRIEL stephane

Identifier Type: -

Identifier Source: org_study_id